BioMarin Pharmaceutical Inc. buy Wells Fargo & Company
Start price
17.09.24
/
50%
€64.04
Target price
17.09.25
€80.92
Performance (%)
-27.97%
End price
18.09.25
€46.13
Summary
This prediction ended on 18.09.25 with a price of €46.13. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -27.97%. Wells_Fargo___Compan has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.143% | -3.143% | -29.415% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Wells_Fargo___Compan for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Wells Fargo & Company from $115.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.07
28.10.25
28.10.25
€60.05
28.10.26
28.10.26
-3.69%
15.12.25
15.12.25
Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.46
27.06.24
27.06.24
€107.36
27.06.25
27.06.25
-39.27%
28.06.25
28.06.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.00
25.04.24
25.04.24
€102.63
25.04.25
25.04.25
-27.92%
26.04.25
26.04.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.32
15.11.23
15.11.23
€92.05
15.11.24
15.11.24
-24.98%
16.11.24
16.11.24